Mucin sialylation drives epithelial cell senescence and severe asthma
粘蛋白唾液酸化导致上皮细胞衰老和严重哮喘
基本信息
- 批准号:10664889
- 负责人:
- 金额:$ 69.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AgonistAsthmaBiological MarkersCCND1 geneCarbohydratesCell AgingCell CommunicationCell CountCell Culture TechniquesCell Differentiation processCell surfaceCellsChronicDataDiseaseERBB2 geneEpidermal Growth Factor ReceptorEpithelial Cell ProliferationEpithelial CellsEpitheliumEvolutionFamilyFamily memberFunctional disorderGene ExpressionGenesGlutathioneGlutathione DisulfideGoblet CellsHumanHuman BiologyHyperplasiaIn VitroInflammationInterleukin-13LinkLungMeasuresMembraneMetabolicMetabolic dysfunctionMetabolic stressMetabolismMitochondriaMucinsMusOxidative StressPathway interactionsPhenotypePost-Translational Protein ProcessingProcessProliferatingProteinsProto-Oncogene Proteins c-aktPublishingPyroglyphidaeReportingRoleSeveritiesSeverity of illnessSialyltransferasesSputumStimulusTNF geneTestingTimeTissuesTransgenic MiceUp-Regulationairway epitheliumasthma exacerbationasthmaticasthmatic airwayasthmatic patientbeta-galactosidecell typedriving forceepithelial woundextracellularglycosylationimprovedin vivomTOR inhibitionmouse modelnew therapeutic targetnoveloxidationparticleprotein expressionreceptorsenescencesialylationwound healing
项目摘要
This application explores the paradigm shifting hypothesis that post-translational modification (sialylation) of a
cell surface (tethered) mucin, MUC4, drives terminal differentiation and senescence of airway epithelial cells
(AECs) through inhibition of epidermal growth factor receptor (EGFR) family pathways, worsening epithelial
wound repair and asthma severity. Our proposed studies will be the first to specifically test tethered mucins and
their post-translational N-glycosylation/sialylation for a role in AEC terminal differentiation and senescence. Our
published data (Zhou et al) demonstrate that sialylation of the tethered mucin, MUC4β, i.e., MUC4α βSA, controls
goblet cell terminal differentiation as a function of β-galactoside α2,6-sialyltransferase-1 (ST6GAL1) activity.
Both ST6GAL1 and MUC4β critically lower AEC proliferative capacity, with additional published data (Inoue et
al) linking diminished AEC proliferation to abnormal wound repair in vitro. Reduced AEC proliferative capacity
may reflect reduced activation of the EGFR family member, ErbB2, a known receptor for MUC4β. New data
confirm that elevations in MUC4 and ST6GAL1 are present in severe exacerbation-prone asthma and in house
dust mite challenged mice. Elevations in both biologically associate with low intracellular glutathione (GSH) to
oxidized glutathione (GSSG) ratios (oxidative stress) and lower mitochondrial and senescence gene expression.
Parallel in vitro AEC data show T2 inflammation/IL-13 alters intracellular metabolism and mitochondria,
decreases GSH/GSSG, and further decreases wound repair. Yet, the overall impact of MUC4β and/or its
sialylation to epithelial cell phenotypes, cell senescence, and the mechanisms by which these changes contribute
to severe asthma are unclear. The studies proposed here will comprehensively evaluate the intersection of
mucins, mucin sialylation, and senescence pathway(s), while robustly testing their functional importance using
primary human AEC cell cultures and transgenic mouse models. The three proposed aims will: 1) elucidate the
mechanistic and functional impact of MUC4β and MUC4βSA on AEC terminal differentiation, senescence and
wound repair in vitro, 2) test the functional impact of Muc4βSA-AEC interactions on mucin secretion, goblet cell
hyperplasia/terminal differentiation, senescence, and wound repair in an asthma mouse model and 3) define the
relationship of MUC4βSA to senescence and AEC phenotypes in human asthma patients. These concurrent aims
will iteratively develop data that link mucins, their sialylation and fundamental senescence-related epithelial
processes to identify highly novel targets for treatment of severe asthma.
该应用程序探讨了范式转换假设,即翻译后修饰(唾液酸化)
细胞表面(束缚)粘蛋白 MUC4 驱动气道上皮细胞的终末分化和衰老
(AEC)通过抑制表皮生长因子受体(EGFR)家族途径,使上皮细胞恶化
我们提出的研究将是第一个专门测试束缚粘蛋白和哮喘严重程度的研究。
它们的翻译后 N-糖基化/唾液酸化在 AEC 终末分化和衰老中发挥作用。
已发表的数据(Zhou 等人)表明,拴系粘蛋白 MUC4β(即 MUC4α βSA)的唾液酸化可以控制
杯状细胞终末分化作为 β-半乳糖苷 α2,6-唾液酸转移酶-1 (ST6GAL1) 活性的函数。
ST6GAL1 和 MUC4β 均严重降低 AEC 增殖能力,并有其他已发表的数据(Inoue 等人,2017)。
al) 将 AEC 增殖减弱与体外伤口修复异常相关。
可能反映了 EGFR 家族成员 ErbB2(一种已知的 MUC4β 受体)的激活减少。
确认 MUC4 和 ST6GAL1 升高存在于严重易发作哮喘和室内
尘螨攻击小鼠的升高与低细胞内谷胱甘肽 (GSH) 的生物学相关。
氧化型谷胱甘肽 (GSSG) 比率(氧化应激)以及较低的线粒体和衰老基因表达。
平行体外 AEC 数据显示 T2 炎症/IL-13 改变细胞内代谢和线粒体,
然而,MUC4β 和/或其的总体影响。
唾液酸化对上皮细胞表型、细胞衰老以及这些变化的机制
与严重哮喘的相关性尚不清楚。此处提出的研究将全面评估两者的交叉点。
粘蛋白、粘蛋白唾液酸化和衰老途径,同时使用以下方法稳健地测试其功能重要性
原代人类 AEC 细胞培养物和转基因小鼠模型。提出的三个目标将:1)阐明
MUC4β和MUC4βSA对AEC终末分化、衰老和功能的影响
体外伤口修复,2) 测试 Muc4βSA-AEC 相互作用对粘蛋白分泌、杯状细胞的功能影响
哮喘小鼠模型中的增生/终末分化、衰老和伤口修复,3) 定义
MUC4βSA 与人类哮喘患者衰老和 AEC 表型的关系。
将迭代开发将粘蛋白、其唾液酸化和基本衰老相关上皮细胞联系起来的数据
确定治疗严重哮喘的高度新颖的靶标的过程。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Bronchial epithelial cell transcriptional responses to inhaled corticosteroids dictate severe asthmatic outcomes.
支气管上皮细胞对吸入皮质类固醇的转录反应决定了严重的哮喘结果。
- DOI:
- 发表时间:2023-06
- 期刊:
- 影响因子:0
- 作者:Ginebaugh, Scott P;Hagner, Matthias;Ray, Anuradha;Erzurum, Serpil C;Comhair, Suzy A A;Denlinger, Loren C;Jarjour, Nizar N;Castro, Mario;Woodruff, Prescott G;Christenson, Stephanie A;Bleecker, Eugene R;Meyers, Deborah A;Hastie, Annette T;Moore
- 通讯作者:Moore
Determining asthma endotypes and outcomes: Complementing existing clinical practice with modern machine learning.
确定哮喘内型和结果:用现代机器学习补充现有的临床实践。
- DOI:
- 发表时间:2022-12-20
- 期刊:
- 影响因子:0
- 作者:Ray, Anuradha;Das, Jishnu;Wenzel, Sally E
- 通讯作者:Wenzel, Sally E
Impact of a pollution breach at a coke oven factory on asthma control in nearby vulnerable adults.
焦炉厂污染违规对附近弱势成年人哮喘控制的影响。
- DOI:10.1016/j.jaci.2021.04.011
- 发表时间:2021-07
- 期刊:
- 影响因子:0
- 作者:Byrwa-Hill BM;Presto AA;Wenzel S;Fabisiak JP
- 通讯作者:Fabisiak JP
Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes.
严重成人哮喘:整合临床特征、生物学和治疗方法以改善结果。
- DOI:
- 发表时间:2021-04-01
- 期刊:
- 影响因子:24.7
- 作者:Wenzel; Sally E
- 通讯作者:Sally E
Real-time imaging of asthmatic epithelial cells identifies migratory deficiencies under type-2 conditions.
哮喘上皮细胞的实时成像可识别 2 型条件下的迁移缺陷。
- DOI:
- 发表时间:2022-02
- 期刊:
- 影响因子:0
- 作者:Jin, Mingzhu;Watkins, Simon;Larriba, Yolanda;Wallace, Callen;St Croix, Claudette;Zhou, Xiuxia;Zhao, Jinming;Peddada, Shyamal;Wenzel, Sally E
- 通讯作者:Wenzel, Sally E
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard Charles Boucher其他文献
Richard Charles Boucher的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard Charles Boucher', 18)}}的其他基金
UNC Research Training Program in Respiratory Diseases and Critical Care
北卡罗来纳大学呼吸系统疾病和重症监护研究培训计划
- 批准号:
10714527 - 财政年份:2023
- 资助金额:
$ 69.55万 - 项目类别:
Diversity Supplement for PhD student Shamarie King under Multi-Scale Investigations of Respiratory Mucus/Mucin Structure and Function in Health and Disease
博士生 Shamarie King 在健康和疾病中呼吸道粘液/粘蛋白结构和功能的多尺度研究中的多样性补充
- 批准号:
10852415 - 财政年份:2022
- 资助金额:
$ 69.55万 - 项目类别:
Multi-Scale Investigations of Respiratory Mucus/Mucin Structure and Function in Health and Disease
健康和疾病中呼吸道粘液/粘蛋白结构和功能的多尺度研究
- 批准号:
10684185 - 财政年份:2022
- 资助金额:
$ 69.55万 - 项目类别:
Project 2: Why are mucins so gigantic and is it safe/effective to sever them therapeutically?
项目 2:为什么粘蛋白如此巨大?在治疗上切断它们是否安全/有效?
- 批准号:
10684198 - 财政年份:2022
- 资助金额:
$ 69.55万 - 项目类别:
The molecular and cellular mechanisms of the STAT3 mutation-mediated pulmonary disorder in Autosomal Dominant Hyper IgE Syndrome (AD-HIES)
常染色体显性高 IgE 综合征 (AD-HIES) STAT3 突变介导的肺部疾病的分子和细胞机制
- 批准号:
10393987 - 财政年份:2022
- 资助金额:
$ 69.55万 - 项目类别:
The molecular and cellular mechanisms of the STAT3 mutation-mediated pulmonary disorder in Autosomal Dominant Hyper IgE Syndrome (AD-HIES)
常染色体显性高 IgE 综合征 (AD-HIES) STAT3 突变介导的肺部疾病的分子和细胞机制
- 批准号:
10584596 - 财政年份:2022
- 资助金额:
$ 69.55万 - 项目类别:
Mucin sialylation drives epithelial cell senescence and severe asthma
粘蛋白唾液酸化导致上皮细胞衰老和严重哮喘
- 批准号:
10206266 - 财政年份:2020
- 资助金额:
$ 69.55万 - 项目类别:
Mucin sialylation drives epithelial cell senescence and severe asthma
粘蛋白唾液酸化导致上皮细胞衰老和严重哮喘
- 批准号:
10026633 - 财政年份:2020
- 资助金额:
$ 69.55万 - 项目类别:
Mucin sialylation drives epithelial cell senescence and severe asthma
粘蛋白唾液酸化导致上皮细胞衰老和严重哮喘
- 批准号:
10434719 - 财政年份:2020
- 资助金额:
$ 69.55万 - 项目类别:
相似国自然基金
蒿属花粉过敏性哮喘集群免疫治疗的生物标志物及作用机制研究
- 批准号:82070033
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
HMGB1介导自噬在TDI哮喘气道炎症和气道重塑中的作用及机制研究
- 批准号:81872603
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
支气管哮喘中医证候、炎症表型及其生物标志物相关性研究
- 批准号:81873278
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
室内空气中PM2.5及其赋存典型内分泌干扰物的污染与暴露
- 批准号:21477072
- 批准年份:2014
- 资助金额:85.0 万元
- 项目类别:面上项目
应用诱导痰转录组学研究重症哮喘内型、筛选预测/治疗生物标志物
- 批准号:81241002
- 批准年份:2012
- 资助金额:10.0 万元
- 项目类别:专项基金项目
相似海外基金
Delineating the Genetic Susceptibility of Smoking-Induced Vascular Dysfunction
描述吸烟引起的血管功能障碍的遗传易感性
- 批准号:
10852366 - 财政年份:2023
- 资助金额:
$ 69.55万 - 项目类别:
Effects of GLP-1 Receptor Agonists on Airway Inflammation and Platelet Activation in Asthma
GLP-1 受体激动剂对哮喘气道炎症和血小板活化的影响
- 批准号:
10523701 - 财政年份:2022
- 资助金额:
$ 69.55万 - 项目类别:
Effects of GLP-1 Receptor Agonists on Airway Inflammation and Platelet Activation in Asthma
GLP-1 受体激动剂对哮喘气道炎症和血小板活化的影响
- 批准号:
10523701 - 财政年份:2022
- 资助金额:
$ 69.55万 - 项目类别:
Effects of GLP-1 Receptor Agonists on Airway Inflammation and Platelet Activation in Asthma
GLP-1 受体激动剂对哮喘气道炎症和血小板活化的影响
- 批准号:
10669261 - 财政年份:2022
- 资助金额:
$ 69.55万 - 项目类别:
Molecular Imaging of the ChemR23-Chemerin Axis in Acute Lung Injury
急性肺损伤中 ChemR23-Chemerin 轴的分子成像
- 批准号:
10441149 - 财政年份:2021
- 资助金额:
$ 69.55万 - 项目类别: